Empliciti is indicated for use in combination with other medications, such as lenalidomide and dexamethasone, in patients who have received one to three prior therapies for multiple myeloma. It may also be used in combination with pomalidomide and dexamethasone for patients who have received at least two prior therapies, including lenalidomide and a proteasome inhibitor.
